Please assess the completion status of the following clinical trial:

Trial Title: The Altis® Single Incision Sling System for Female Stress Urinary Incontinence Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is female at least 18 years of age~* Subject is able and willing to complete all procedures and follow-up visits indicated in this protocol~* Subject has confirmed stress urinary incontinence (SUI) through cough stress test or urodynamics~* The subject has failed two non-invasive incontinence therapies (such as Kegel exercise, behavior modification, pad use, biofeedback, etc) for \>6 months~Exclusion Criteria:~* Subject has an active urogenital infection or active skin infection in region of surgery~* Subject has confirmed Pelvic Organ Prolapse (POP) of Stage 2 or higher as determined by POP-Q prolapse grading~* Subject is having a concomitant pelvic floor procedure~* Subject has incontinence due to neurogenic causes (e.g. multiple sclerosis, spinal cord/brain injury, cerebrovascular accident, detrusor-external sphincter dyssynergia, Parkinson's disease, or similar conditions)~* Subject had a prior surgical SUI treatment~* Subject has undergone radiation or brachy therapy to treat pelvic cancer~* Subject has urge predominant incontinence~* Subject has an atonic bladder or a post void residual (PVR) consistently about 100cc~* Subject is pregnant and/or is planning to get pregnant in the future~* Subject has a contraindication to the surgical procedure or the Altis Instructions For Use (IFU)~* Subject is enrolled in a concurrent clinical trial of any treatment (drug or device) that could affect continence function without the sponsor's approval

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Altis® SIS (Type: OTHER): Subjects enrolled with Altis® SIS

Based on this trial design, predict the completion outcome and termination type (if applicable).